Literature DB >> 24093038

[Not Available].

Josiane Bégin1, Marianne Guay, Stéphanie Ricard, Maxime Doré, Anne-Marie Mansour.   

Abstract

Year:  2013        PMID： 24093038      PMCID： PMC3785193          DOI： 10.1177/1715163513499522

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  19 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  HLA-B* 1502 screening: time to clinical practice.

Authors:  Chaichon Locharernkul; Vorasuk Shotelersuk; Nattiya Hirankarn
Journal:  Epilepsia       Date:  2010-05       Impact factor: 5.864

3.  HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Authors:  Kongkiat Kulkantrakorn; Wichittra Tassaneeyakul; Somsak Tiamkao; Thawinee Jantararoungtong; Napat Prabmechai; Suda Vannaprasaht; Pansu Chumworathayi; Pei Chen; Paskorn Sritipsukho
Journal:  Pain Pract       Date:  2011-06-16       Impact factor: 3.183

4.  Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.

Authors:  Na He; Fu-Li Min; Yi-Wu Shi; Jing Guo; Xiao-Rong Liu; Bing-Mei Li; Jin-Hua Zhou; Yang-Mei Ou; Jian-Xiang Liao; Wei-Ping Liao
Journal:  Seizure       Date:  2012-07-20       Impact factor: 3.184

5.  Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.

Authors:  Sae-Hoon Kim; Kyung Wha Lee; Woo-Jung Song; Sang-Heon Kim; Young-Koo Jee; Sang-Min Lee; Hye-Ryun Kang; Heung-Woo Park; Sang-Heon Cho; Seong-Ho Park; Kyung-Up Min; Yoon-Seok Chang
Journal:  Epilepsy Res       Date:  2011-09-13       Impact factor: 3.045

Review 6.  Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.

Authors:  Chaichon Locharernkul; Vorasuk Shotelersuk; Nattiya Hirankarn
Journal:  J Clin Neurosci       Date:  2011-07-28       Impact factor: 1.961

Review 7.  A recent update of pharmacogenomics in drug-induced severe skin reactions.

Authors:  Chun-Yu Wei; Tai-Ming Ko; Chen-Yang Shen; Yuan-Tsong Chen
Journal:  Drug Metab Pharmacokinet       Date:  2011-11-01       Impact factor: 3.614

8.  Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Authors:  Pei Chen; Juei-Jueng Lin; Chin-Song Lu; Cheung-Ter Ong; Peiyuan F Hsieh; Chih-Chao Yang; Chih-Ta Tai; Shey-Lin Wu; Cheng-Hsien Lu; Yung-Chu Hsu; Hsiang-Yu Yu; Long-Sun Ro; Chung-Ta Lu; Chun-Che Chu; Jing-Jane Tsai; Yu-Hsiang Su; Sheng-Hsing Lan; Sheng-Feng Sung; Shu-Yi Lin; Hui-Ping Chuang; Li-Chen Huang; Ying-Ju Chen; Pei-Joung Tsai; Hung-Ting Liao; Yu-Hsuan Lin; Chien-Hsiun Chen; Wen-Hung Chung; Shuen-Iu Hung; Jer-Yuarn Wu; Chi-Feng Chang; Luke Chen; Yuan-Tsong Chen; Chen-Yang Shen
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

Review 9.  Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.

Authors:  Erik Letko; Dean N Papaliodis; George N Papaliodis; Yassine J Daoud; A Razzaque Ahmed; C Stephen Foster
Journal:  Ann Allergy Asthma Immunol       Date:  2005-04       Impact factor: 6.347

10.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Authors:  J C Roujeau; J P Kelly; L Naldi; B Rzany; R S Stern; T Anderson; A Auquier; S Bastuji-Garin; O Correia; F Locati
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.